Retraction notice to “A novel compound DSC suppresses lipopolysaccharide-induced inflammatory responses by inhibition of Akt/NF-κB signalling in macrophages" [Eur. J. Pharmacol. 708/1–3 (2013) 8–13, (S0014299913000204), (10.1016/j.ejphar.2013.01.013)];A novel compound DSC suppresses lipopolysaccharide-induced inflammatory responses by inhibition of Akt/NF-κB signalling in macrophages

European Journal of Pharmacology

Volumn 708, Issue 1-3, 2013, Pages 8-13

  Liu, Xin Hua ^a   Pan, Li Long ^a   Jia, Yao Ling ^a   Wu, Dan ^a   Xiong, Qing Hui ^a   Wang, Yang ^a   Zhu, Yi Zhun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Danshensu cysteine derivative; Inducible nitric oxide synthase; Inflammation; Lipopolysaccharide; Nitric oxide

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; 4 [2 ACETOXY 3 [3 (BENZYLTHIO) 1 METHOXY 1 OXOPROPAN 2 YLAMINO] 3 OXOPROPYL] 1,2 PHENYLENE DIACETIC ACID; ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE 1; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROTECTION; CELL TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; INFLAMMATION; INTRACELLULAR SIGNALING; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 84877793614     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2024.176993     Document Type: Erratum

References (22)

1. S. Akira, and K. Takeda Toll-like receptor signalling Nat. Rev. Immunol. 4 2004 499 511
2. T.O. Cheng Cardiovascular effects of Danshen Int. J. Cardiol. 121 2007 9 22
3. M. Ding, T.X. Ye, G.R. Zhao, Y.J. Yuan, and Z.X. Guo Aqueous extract of Salvia miltiorrhiza attenuates increased endothelial permeability induced by tumor necrosis factor-alpha Int. Immunopharmacol. 5 2005 1641 1651
4. C. Dong, Y. Wang, and Y.Z. Zhu Asymmetric synthesis and biological evaluation of Danshensu derivatives as anti-myocardial ischemia drug candidates Bioorg. Med. Chem. 17 2009 3499 3507
5. S. Gao, Z. Liu, H. Li, P.J. Little, P. Liu, and S. Xu Cardiovascular actions and therapeutic potential of tanshinone IIA Atherosclerosis 220 2012 3 10
6. H.J. Ho, D.Y. Huang, F.M. Ho, L.T. Lee, and W.W. Lin Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase expression by endoplasmic reticulum stress Cell Signal. 24 2012 2166 2178
7. Y. Jia, X. Dong, P. Zhou, X. Liu, L. Pan, H. Xin, Y.Z. Zhu, and Y. Wang The synthesis and biological evaluation of novel Danshensu-cysteine analog conjugates as cardiovascular-protective agents Eur. J. Med. Chem. 55 2012 176 187
8. E.H. Joh, and D.H. Kim Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-kappaB and MAPK pathways B. J. Pharmacol. 162 2011 1731 1742
9. J.H. Kim, G. Lee, Y.L. Cho, C.K. Kim, S. Han, H. Lee, J.S. Choi, J. Choe, M.H. Won, Y.G. Kwon, K.S. Ha, and Y.M. Kim Desmethylanhydroicaritin inhibits NF-kappaB-regulated inflammatory gene expression by modulating the redox-sensitive PI3K/PTEN/Akt pathway Eur. J. Pharmacol. 602 2009 422 431
10. T. Kondo, T. Kawai, and S. Akira Dissecting negative regulation of Toll-like receptor signaling Trends Immunol. 33 2012 449 458
11. F.F. Lam, J.H. Yeung, Y.W. Kwan, K.M. Chan, and P.M. Or Salvianolic acid B, an aqueous component of danshen (Salvia miltiorrhiza), relaxes rat coronary artery by inhibition of calcium channels Eur. J. Pharmacol. 553 2006 240 245
12. M. Li, C. Zhao, R.N. Wong, S. Goto, Z. Wang, and F. Liao Inhibition of shear-induced platelet aggregation in rat by tetramethylpyrazine and salvianolic acid B Clin. Hemorheol. Microcirc. 31 2004 97 103
13. Q. Li, and I.M. Verma NF-kappaB regulation in the immune system Nat. Rev. Immunol. 2 2002 725 734
14. Y.C. Lin, H.C. Kuo, J.S. Wang, and W.W. Lin Regulation of inflammatory response by 3-methyladenine involves the coordinative actions on Akt and glycogen synthase kinase 3beta rather than autophagy J. Immunol. 189 2012 4154 4164
15. X.H. Liu, L.L. Pan, Q.H. Gong, and Y.Z. Zhu Antiapoptotic effect of novel compound from Herba leonuri - leonurine (SCM-198): a mechanism through inhibition of mitochondria dysfunction in H9c2 cells Curr. Pharm. Biotechnol. 11 2010 895 905
16. L.V. Madrid, M.W. Mayo, J.Y. Reuther, and A.S. Baldwin Jr. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38 J. Biol. Chem. 276 2001 18934 18940
17. R. Medzhitov Origin and physiological roles of inflammation Nature 454 2008 428 435
18. D.M. Mosser, and J.P. Edwards Exploring the full spectrum of macrophage activation Nat. Rev. Immunol. 8 2008 958 969
19. L.L. Pan, X.H. Liu, Q.H. Gong, D. Wu, and Y.Z. Zhu Hydrogen sulfide attenuated tumor necrosis factor-alpha-induced inflammatory signaling and dysfunction in vascular endothelial cells PLoS One 6 2011 e19766
20. X. Xie, S. Wang, L. Xiao, J. Zhang, J. Wang, J. Liu, X. Shen, D. He, X. Zheng, and Y. Zhai DBZ blocks LPS-induced monocyte activation and foam cell formation via inhibiting nuclear factor-kB Cell Physiol. Biochem. 28 2011 649 662
21. G. Zhang, and S. Ghosh Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity J. Clin. Invest. 107 2001 13 19
22. L. Zhou, Z. Zuo, and M.S. Chow Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use J. Clin. Pharmacol. 45 2005 1345 1359